AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+2.4%/yr
Long-term compound
Percentile
P49
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.18% |
| Q3 2025 | 1.91% |
| Q2 2025 | 13.30% |
| Q1 2025 | -3.01% |
| Q4 2024 | 7.70% |
| Q3 2024 | -11.62% |
| Q2 2024 | 21.37% |
| Q1 2024 | -3.48% |
| Q4 2023 | 7.54% |
| Q3 2023 | -6.17% |
| Q2 2023 | 70.24% |
| Q1 2023 | -7.52% |
| Q4 2022 | -14.08% |
| Q3 2022 | -10.34% |
| Q2 2022 | 16.50% |
| Q1 2022 | -20.84% |
| Q4 2021 | -2.12% |
| Q3 2021 | 12.77% |
| Q2 2021 | 9.13% |
| Q1 2021 | -9.85% |
| Q4 2020 | 4.61% |
| Q3 2020 | 15.23% |
| Q2 2020 | 14.39% |
| Q1 2020 | 20.07% |
| Q4 2019 | -7.54% |
| Q3 2019 | 1.48% |
| Q2 2019 | 29.01% |
| Q1 2019 | 33.93% |
| Q4 2018 | -46.63% |
| Q3 2018 | 18.60% |
| Q2 2018 | 11.87% |
| Q1 2018 | -35.90% |
| Q4 2017 | 11.81% |
| Q3 2017 | 39.14% |
| Q2 2017 | -16.90% |
| Q1 2017 | -19.93% |
| Q4 2016 | 8.99% |
| Q3 2016 | 9.39% |
| Q2 2016 | 9.70% |
| Q1 2016 | -4.40% |